Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

In a report released on December 5, John Heinbockel from Guggenheim maintained a Buy rating on Dollar General, with a price target of $140.00. The ...

Dollar General (DG) Receives a Buy from Guggenheim

Jefferies analyst Corey Tarlowe maintained a Buy rating on Dollar General today and set a price target of $142.00. According to TipRanks, Tarlowe i...

Jefferies Sticks to Its Buy Rating for Dollar General (DG)

Dollar General received a Hold rating and price target from Truist Financial analyst Scot Ciccarelli today. According to TipRanks, Ciccarelli is a ...

Dollar General (DG) Receives a New Rating from a Top Analyst

Dollar General Corp ( ($DG) ) has released its Q3 earnings. Here is a breakdown of the information Dollar General Corp presented to its investors. ...

Dollar General Reports Strong Q3 2025 Results

In a report released on November 25, Edward Kelly from Wells Fargo maintained a Hold rating on Dollar General, with a price target of $115.00. The ...

Dollar General (DG) Gets a Hold from Wells Fargo

China Dongxiang (Group) Co ( ($HK:3818) ) just unveiled an update. China Dongxiang (Group) Co., Ltd. reported its interim results for the six month...

China Dongxiang Reports Strong Interim Profit Growth Despite Revenue Dip

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Quest Diagnostics, with a price target of $195.00. Sergott cover...

Quest Diagnostics (DGX) Gets a Hold from Barclays

Mizuho Securities analyst Ann Hynes reiterated a Buy rating on Quest Diagnostics yesterday. The company’s shares closed yesterday at $185.96. Hynes...

Quest Diagnostics (DGX) Receives a Buy from Mizuho Securities

Digi Power X ( ($TSE:DGX) ) has issued an announcement. On November 18, 2025, Digi Power X Inc. announced the filing of an amended and restated pro...

Digi Power X Updates Equity Program with New Prospectus

Digihost Technology Inc ( ($DGXX) ) has released its Q3 earnings. Here is a breakdown of the information Digihost Technology Inc presented to its i...

Digi Power X Reports Positive Q3 Earnings and Strategic Growth

Digi Power X ( ($TSE:DGX) ) just unveiled an update. Digi Power X reported positive net earnings for Q3 2025, marking a significant turnaround from...

Digi Power X Achieves Profitability and Advances AI Infrastructure Plans

Dollar General ( ($DG) ) has shared an announcement. On November 12, 2025, Dollar General Corporation announced the appointment of Emily C. Taylor ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$182.56	+0.55%	1.14M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$182.56	+0.5%	1.14M
3
4
5
6

DGX

DGX

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel